Turmeric (Curcuma longa L., Zingiberaceae) has a long history of use in medicine for the treatment of inflammatory conditions.
INTRODUCTION
Colorectal cancer (CRC), the third most common malignant neoplasm with the second leading cause of death worldwide, is related to inflammatory bowel disease (IBD) including ulcerative colitis and Crohn's disease. 1 As chronic inflammation has been recognized as an essential risk factor for a variety of human malignancies, 2 alleviating inflammation is an important strategy for chemoprevention. Chemoprevention is a strategy of use of nontoxic chemicals such as phytochemicals to inhibit, retard, or reverse the process of multistage carcinogenesis. 3 Curcumin (Fig. 1A) , the major yellow colouring pigment found in the household spice turmeric (Curcuma longa Linn, Zingiberaceae), has been used for centuries in food preparation as well as in Ayurvedic traditional medicine to treat inflammatory disorders. 4 Curcumin has low toxicity and has been shown to be effective for the treatment of chronic gut inflammation in an animal model, and also beneficial in a randomised cross-over trial in the treatment of ulcerative colitis. 5 The transcription factor STAT3 is has been reported to play a role in colonic inflammation. 6 STAT3 is a transcription factor activated by a variety of cytokines and growth factors. 7, 8 Upon activation, STAT3 translocates to the nucleus, where it regulates genes involved in apoptosis (e.g., Bcl-X1), cell cycle regulator (e.g., cyclin D1), migration, and survival depending on the cell types. 9, 10 Although the inhibitory effect of curcumin on DSSinduced mouse colitis has been reported, 11 the detailed molecular mechanism is still unclear. This prompted us to investigate the effects of curcumin on activation of STAT3, a key transcription factor involved in inflammatory signaling, in the colon of mice challenged with DSS.
MATERIALS AND METHODS
Materials
Curcumin was obtained from LKT laboratories (Minneapolis, MN, USA). DSS with a molecular weight of 36,000-50,000 was obtained from MP Biomedical Inc.
(Solon, OH, USA 
Electrophoresis mobility shift assay (EMSA)
The EMSA for STAT3 DNA binding was performed using a DNA-protein binding assay kit, according to the manu- and p21. Whole tissue lysates from different treatment groups were separated by 10% SDS-polyacrylamide gel and immunoblotted by using antibody specific for detecting p53 or p21.
the gel was dried and exposed to X-ray film.
Statistics
Values were expressed as the mean±SEM of at least three independent experiments. Statistical significance was determined by Student's t-test and P＜0.05 was considered to be statistically significant.
RESULTS

Curcumin inhibits DSS-induced DNA binding of STAT3 in mouse colon
STAT3 contributes to colitis-associated colorectal cancer through transcriptional activation of diverse pro-inflammatory and proliferative genes. 12 Our study revealed that the DNA binding of STAT3 was markedly increased in colon tissue of mice challenged with DSS alone, while administration of curcumin by gavage significantly negated DSS-induced STAT3 DNA binding ( Fig. 2A) . Mechanistically, STAT3 is activated through phosphorylation of tyrosine 705 residue by a variety of protein tyrosine kinases. 13 Western blot analyses revealed that curcumin suppressed DSS-induced phosphorylation of STAT3 in mouse colon (Fig. 2B ).
Curcumin attenuates DSS-induced expression of cyclin D1 and CDK4 in mouse colon
Colitis, which often turns into colorectal cancer, is associated with increased cell proliferation. One of the cell cycle regulatory proteins is cyclin D1, which by forming a complex with Cdk4, promotes cell cycle progression. The expression of both Cyclin D1 and Cdk4 is transcriptionally regulated by STAT3. DSS treatment elevated the expression of cyclin D1 in mouse colon, which was attenuated by administration of curcumin (Fig. 3) . Likewise, curcumin inhibited DSS-induced expression of CDK4 in mouse colon (Fig. 3) .
Curcumin inhibits DDS-induced expression of p53
p53 is a key biosensor of inflammatory stress. Since p53 is activated by phosphorylation during inflammation stress, 14 we investigated the level of p53 to measure the degree of acute inflammation. Expression levels of p53 and its target protein p21 were elevated by DSS treatment and it was inhibited by curcumin (Fig. 4) .
DISCUSSION
Despite many anticancer treatments have been developed, cancer is still a global health problem with severe morbidity and mortality. As cancer is a multi-step process typically occurring over an extended period beginning with initiation followed by promotion and progression, the preventive strategy to reduce the risk of cancer development is important. 15 One such example is chemoprevention. The goals of chemoprevention are to block, retard or reverse the process of carcinogenesis, using non-toxic substances of natural or synthetic origin. 15, 16 Dietary phytochemicals such as capsicin, resveratrol, curcumin have been known to prevent the initiation and promotion of multistep carcinogenesis. 15, 16 Curcumin is a polyphenol and pharmacologically active compound of the perennial herb Curcuma longa (commonly known as turmeric). Traditionally, turmeric has been used for a foodstuff, cosmetic, and medicine. As a spice, turmeric has been used to provide curry with its distinctive yellow color and flavor. 17 In folk medicine, turmeric and natural curcuminoids have been used as therapeutic treatment over the centuries in different parts of the world. In traditional Chinese herbal medicine, it is used to treat diseases associated with abdominal pain. 18 In ancient Hindu medicine, it was used to treat sprains and swelling. 19 Throughout the Orient history, it has traditionally been used as a good therapeutic medication, particularly as an anti-inflammatory, 20 and many of its therapeutic effects have been confirmed by modern scien- Bcl-xL. 27 In this study, we found that curcumin suppressed DNA binding of STAT3 in DSS-stimulated mouse colon. In addition, we also found that curcumin inhibited DSSinduced phosphorylation of STAT3 in mouse colon. Cyclin D1 has been reported to be associated with cell proliferation and regulated by NF-κB and STAT3. 13, 28 Moreover, CDK4 is a protein that forms a complex with cyclin D1 and thereby regulates G1 to S cell cycle progression. So, we determined the levels of cyclin D1 and CDK4 in each group and found that curcumin inhibited DSS-induced expression of cyclin D1 and CDK4.
p53 is a key biosensor of inflammatory stress and activated by phosphorylation during inflammation. 14 Therefore, we investigated the level of p53 to measure the degree of acute inflammation. p53 was induced by DSS treatment and it was inhibited by curcumin in a dose-dependent manner.
Taken together, the above findings suggest that oral administration of curcumin provokes anti-inflammatory effects by inhibiting the STAT3. In addition, curcumin also elicits anti-proliferative effects through suppression cyclin D1, CDK4 expression, which is likely to be mediated by blocking STAT3 signaling. Considering STAT3 as a potential molecular link between inflammation and cancer and the role of aberrantly overexpressed cyclin D1 in tumor promotion, the present study provides the molecular basis for the previously reported chemopreventive effects of curcumin.
